painkillers

Insys's 'reckless' Subsys marketing led to patient's death, lawsuit alleges
Insys's 'reckless' Subsys marketing led to patient's death, lawsuit alleges
Fierce Pharma
Insys
Subsys
patients
painkillers
off-label
Flag link:
Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO™ ER
Egalet Deploys Salesforce to Begin Educating Healthcare Providers about ARYMO™ ER
Yahoo
Egalet
opioids
painkillers
Arymo ER
Flag link:
Nektar's opioid painkiller succeeds in key late-stage study
Nektar's opioid painkiller succeeds in key late-stage study
Yahoo/Reuters
Nektar
painkillers
opioids
clinical trials
Flag link:
No opioids, please: A growing movement lets patients refuse prescriptions
No opioids, please: A growing movement lets patients refuse prescriptions
Stat
opioids
painkillers
patients
Flag link:
FDA panel: Endo opioid painkiller's risks outweigh its benefits
FDA panel: Endo opioid painkiller's risks outweigh its benefits
Bizjournals.com
FDA
advisory panels
Endo International
Opana ER
opioids
painkillers
Flag link:
Cara Therapeutics is betting on its new pain drug. Maybe investors should, too.
Cara Therapeutics is betting on its new pain drug. Maybe investors should, too.
Motley Fool
Cara Therapeutics
painkillers
CR845
kappa opioid receptors
Flag link:
Former execs charged with bribing doctors to prescribe potent painkiller
Former execs charged with bribing doctors to prescribe potent painkiller
Stat
painkillers
physicians
INSYS Therapeutics
Subsys
Flag link:
Card-carrying pharma reps? Chicago eyes licensing for painkiller promoters
Card-carrying pharma reps? Chicago eyes licensing for painkiller promoters
Fierce Pharma
drug reps
opioids
painkillers
chicago
Flag link:
Pain at Insys Therapeutics
Pain at Insys Therapeutics
CP Wire
INSYS Therapeutics
opioids
Subsys
painkillers
John Kapoor
Flag link:
[video] A Billionaire And His Controversial Opioid
[video] A Billionaire And His Controversial Opioid
Forbes
John Kapoor
Subsys
INSYS Therapeutics
opioids
painkillers
Flag link:
Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab
Teva, Regeneron enter deal potentially worth up to $2.6 billion to develop pain therapy fasinumab
First Word Pharma
Teva Pharmaceutical
Regeneron
fasinumab
painkillers
Flag link:
AcelRx's opioid painkiller succeeds in key study
AcelRx's opioid painkiller succeeds in key study
Yahoo/Reuters
AcelRx
opioids
painkillers
clinical trials
Flag link:
FDA to require strong warnings about combining pain pills with anxiety medication
FDA to require strong warnings about combining pain pills with anxiety medication
Stat
FDA
warnings
painkillers
anxiety
opioids
benzodiazepines
Flag link:
Endo Pharma to withdraw application for new opioid painkiller formulation
Endo Pharma to withdraw application for new opioid painkiller formulation
Marketwatch
Endo Pharmaceutical
opioids
painkillers
Opana ER
Flag link:
Pfizer's Bextra settlement tagged at $486M
Pfizer's Bextra settlement tagged at $486M
Fierce Pharma
Pfizer
Bextra
Celebrex
painkillers
Flag link:
FDA overrides adcomm, shoots down KemPharm’s opioid
FDA overrides adcomm, shoots down KemPharm’s opioid
Fierce Biotech
FDA
advisory panels
KemPharm
Apadaz
opioids
painkillers
Flag link:
FDA panel backs approval of Pfizer's opioid painkiller
FDA panel backs approval of Pfizer's opioid painkiller
Yahoo/Reuters
FDA
advisory panels
Pfizer
opioids
painkillers
Troxyca ER
Flag link:
Revenues From Opioids Drying Up For Pharmaceuticals
Revenues From Opioids Drying Up For Pharmaceuticals
Seeking Alpha
opioids
painkillers
KemPharm
Pfizer
Teva Pharmaceuticals
Flag link:
Lilly says new type of pain drug could lessen need for opioids
Lilly says new type of pain drug could lessen need for opioids
Yahoo/Reuters
Eli Lilly
painkillers
tanezumab
chronic pain
opioids
Flag link:
Panel: Painkiller training should be required for physicians
Panel: Painkiller training should be required for physicians
Yahoo/AP
painkillers
physicians
FDA
opioids
Flag link: